Pfizer, Doctors, Sales and Trust
NEW YORK (Reuters) – Pfizer Inc. said last week it would cut its U.S. sales force by about 20 percent, or some 2,200 jobs, as part of a comprehensive cost-cutting program. Good move. Wrong reason. Pfizer is the world’s largest pharmaceutical maker, with a vaunted sales force. The cut is big news. But at least […]